Great information JP. This gives me a whole perspective of the company and what Josh is trying to build. We could be in for a wild ride, although it may also be a long time coming.
The medical cannabis industry in Israel is flourishing thanks in part to budding growing ties with Canada, which will officially legalize marijuana in October. Hundreds of millions of dollars in deals between companies in Canada and Israel have already been inked. So what's holding the industry back? Israeli government regulation.
1. The YT clip above shows the possible opportunities available to Cann10 NA and BLDV as the medical cannabis trade between Israel and Canada is growing; this is a segment of the cannabis market that Cann10 works in.
2. Combining Cann10 NA's efforts in this segment with the information presented in the YT clip above and the possibility of uplisting to the CSE mentioned in previous PRs possibly explains the potential opportunities and motivation that Cann10 NA has to want to possibly be listed in Canada in the future. However, the current Israeli government regulations are not allowing the exports which is hindering the growth in trade. It will be interesting to see how Cann10 and BLDV approach these challenges as opportunities and research coming out of Israel continue to develop in the medical cannabis segment (i.e. Israeli knowledge and technology).
3. Notice how the Cann10 logo appears on the right at 0:06 in the YT clip above.
TRENDING | As medical marijuana is more and more stagnant in the United States, researchers and advocates for its use have come to Israel to work and collect findings. Dr. Hinanit Koltai and Joshua Horn discuss with Emily Frances.
1. Overall I think this Israeli news broadcast demonstrates how Israel is leading medical cannabis research through cooperation between the Israeli federal government to support clinical trials and research. These efforts demonstrate how Cann10 and BLDV can possibly build Cann10 NA to become successful.
2. 3:14 - Notice how Dr. Hinanit Koltai states that evidence-based medicine is completely absent from medical cannabis. I think this point is at the core of Cann10's strategy to monetize this absent research and knowledge.
3. 3:41 - Dr. Koltai states that cannabis contains about 500 compounds and at 4:02 she mentions that there is a strong entourage effect. Notice how these two comments are very similar to Dr Meiri's comments in his presentation, link back to previous post. Note that Dr. Meiri is presenting at CannX along with the BLDV CEO:
News 
Market Data 
Discover 
